57 related articles for article (PubMed ID: 21668308)
1. Broad-spectrum immunosuppression by classless monocytes in non-Hodgkin's lymphoma.
Vari F; Gandhi MK
Immunotherapy; 2011 Jun; 3(6):723-6. PubMed ID: 21668308
[TBL] [Abstract][Full Text] [Related]
2. Immunosuppressive CD14+HLA-DR(low)/- monocytes in B-cell non-Hodgkin lymphoma.
Lin Y; Gustafson MP; Bulur PA; Gastineau DA; Witzig TE; Dietz AB
Blood; 2011 Jan; 117(3):872-81. PubMed ID: 21063024
[TBL] [Abstract][Full Text] [Related]
3. Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study.
Ruco LP; Pomponi D; Pigott R; Stoppacciaro A; Monardo F; Uccini S; Boraschi D; Tagliabue A; Santoni A; Dejana E
Am J Pathol; 1990 Nov; 137(5):1163-71. PubMed ID: 1700619
[TBL] [Abstract][Full Text] [Related]
4. Association of human leukocyte antigen ancestral haplotype 8.1 with adverse outcome of non-Hodgkin's lymphoma.
Nowak J; Kalinka-Warzocha E; Juszczynski P; Bilinski P; Mika-Witkowska R; Zajko M; Bienvenu J; Coiffier B; Salles G; Warzocha K
Genes Chromosomes Cancer; 2007 May; 46(5):500-7. PubMed ID: 17311253
[TBL] [Abstract][Full Text] [Related]
5. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T
J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384
[TBL] [Abstract][Full Text] [Related]
6. CD14
Zhou J; Xiao H; Wang Z; Wang H; Liang X; Zhai Z; Hong J
Immunol Cell Biol; 2024 Apr; 102(4):256-268. PubMed ID: 38361210
[TBL] [Abstract][Full Text] [Related]
7. Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma.
Feldmann G; Nischalke HD; Nattermann J; Banas B; Berg T; Teschendorf C; Schmiegel W; Dührsen U; Halangk J; Iwan A; Sauerbruch T; Caselmann WH; Spengler U
Clin Cancer Res; 2006 Aug; 12(15):4491-8. PubMed ID: 16899594
[TBL] [Abstract][Full Text] [Related]
8. Low HLA-DR expression on CD14+ monocytes of burn victims with sepsis, and the effect of carbachol in vitro.
Yang HM; Yu Y; Chai JK; Hu S; Sheng ZY; Yao YM
Burns; 2008 Dec; 34(8):1158-62. PubMed ID: 18538934
[TBL] [Abstract][Full Text] [Related]
9. Autologous stem-cell transplantation restores the functional properties of CD14+CD16+ monocytes in patients with myeloma and lymphoma.
Dayyani F; Joeinig A; Ziegler-Heitbrock L; Schmidmaier R; Straka C; Emmerich B; Meinhardt G
J Leukoc Biol; 2004 Feb; 75(2):207-13. PubMed ID: 14576364
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of the morphological, cytochemical, immunophenotypical, and functional characteristics of normal human peripheral blood lineage(-)/CD16(+)/HLA-DR(+)/CD14(-/lo) cells, CD14(+) monocytes, and CD16(-) dendritic cells.
Almeida J; Bueno C; Algueró MC; Sanchez ML; de Santiago M; Escribano L; Díaz-Agustín B; Vaquero JM; Laso FJ; San Miguel JF; Orfao A
Clin Immunol; 2001 Sep; 100(3):325-38. PubMed ID: 11513546
[TBL] [Abstract][Full Text] [Related]
11. Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes.
Hillinger SM; Herzig GP
J Clin Invest; 1978 Jun; 61(6):1620-7. PubMed ID: 149140
[TBL] [Abstract][Full Text] [Related]
12. HLA DR-DQ combination associated with the increased risk of developing human HCV positive non-Hodgkin's lymphoma is related to the type II mixed cryoglobulinemia.
De Re V; Caggiari L; Monti G; Libra M; Spina M; Dolcetti R; De Zorzi M; Racanelli V; Crovatto M; Toffoli G
Tissue Antigens; 2010 Feb; 75(2):127-35. PubMed ID: 20002609
[TBL] [Abstract][Full Text] [Related]
13. Peripheral T cells of patients with B cell non-Hodgkin's lymphoma show a shift in their memory status.
Atanackovic D; Panse J; Schafhausen P; Faltz C; Bartels K; Boeters I; Hossfeld DK; Hegewisch-Becker S
Leuk Res; 2005 Sep; 29(9):1019-27. PubMed ID: 16038728
[TBL] [Abstract][Full Text] [Related]
14. Can CD3+/HLA-DR+ activated T cells predict the prognosis of non-Hodgkin's lymphoma patients?
Váróczy L; Gergely L; Miltényi Z; Aleksza M; Illés A
Immunol Lett; 2005 Feb; 97(1):155-7. PubMed ID: 15626488
[TBL] [Abstract][Full Text] [Related]
15. Prevalence, clinical pattern, and outcome of CNS involvement in childhood and adolescent non-Hodgkin's lymphoma differ by non-Hodgkin's lymphoma subtype: a Berlin-Frankfurt-Munster Group Report.
Salzburg J; Burkhardt B; Zimmermann M; Wachowski O; Woessmann W; Oschlies I; Klapper W; Wacker HH; Ludwig WD; Niggli F; Mann G; Gadner H; Riehm H; Schrappe M; Reiter A
J Clin Oncol; 2007 Sep; 25(25):3915-22. PubMed ID: 17761975
[TBL] [Abstract][Full Text] [Related]
16. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
Masucci G; Mellstedt H; Masucci MG; Szigeti R; Ernberg I; Björkholm M; Tsukuda K; Henle G; Henle W; Pearson G
Cancer Res; 1984 Mar; 44(3):1288-300. PubMed ID: 6318984
[TBL] [Abstract][Full Text] [Related]
17. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED
Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984
[TBL] [Abstract][Full Text] [Related]
18. The relationship of HLA-DR, CD38 and CD71 markers to activation, proliferation and differentiation of some human leukemia and lymphoma cells.
Glasová M; Koníková E; Stasáková J; Babusíková O
Neoplasma; 1998; 45(2):88-95. PubMed ID: 9687889
[TBL] [Abstract][Full Text] [Related]
19. Transgenic expression of CD40L and interleukin-2 induces an autologous antitumor immune response in patients with non-Hodgkin's lymphoma.
Takahashi S; Yotnda P; Rousseau RF; Mei Z; Smith S; Rill D; Younes A; Brenner MK
Cancer Gene Ther; 2001 May; 8(5):378-87. PubMed ID: 11477458
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease.
Albitar M; Vose JM; Johnson MM; Do KA; Day A; Jilani I; Kantarjian H; Keating M; O'Brien SM; Verstovsek S; Armitage JO; Giles FJ
Leuk Res; 2007 Feb; 31(2):139-45. PubMed ID: 16545870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]